Authors:
Chappuis, PO
Hamel, N
Paradis, AJ
Deschenes, J
Tonin, PN
Ghadirian, P
Foulkes, WD
Citation: Po. Chappuis et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients, J NAT CANC, 93(2), 2001, pp. 152-153
Authors:
Tonin, PN
Hudson, TJ
Rodier, F
Bossolasco, M
Lee, PD
Novak, J
Manderson, EN
Provencher, D
Mes-Masson, AM
Citation: Pn. Tonin et al., Microarray analysis of gene expression mirrors the biology of an ovarian cancer model, ONCOGENE, 20(45), 2001, pp. 6617-6626
Authors:
Tonin, PN
Perret, C
Lambert, JA
Paradis, AJ
Kantemiroff, T
Benoit, MH
Martin, G
Foulkes, WD
Ghadirian, P
Citation: Pn. Tonin et al., Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history, INT J CANC, 95(3), 2001, pp. 189-193
Authors:
Manning, AP
Abelovich, D
Ghadirian, P
Lambert, JA
Frappier, D
Provencher, D
Robidoux, A
Peretz, T
Narod, SA
Mes-Masson, AM
Foulkes, WD
Wang, TL
Morgan, K
Fujiwara, TM
Tonin, PN
Citation: Ap. Manning et al., Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families, HUMAN HERED, 52(2), 2001, pp. 116-120
Authors:
Khittoo, G
Manning, A
Mustun, H
Appadoo, J
Venkatasamy, S
Fagoonee, I
Ghadirian, P
Tonin, PN
Citation: G. Khittoo et al., Mutation analysis of a Mauritian hereditary breast cancer family reveals the BRCA2 6503delTT mutation previously found to recur in different ethnic populations, HUMAN HERED, 52(1), 2001, pp. 55-58
Authors:
Singh, R
Eeles, RA
Durocher, F
Simard, J
Edwards, S
Badzioch, M
Kote-Jarai, Z
Teare, D
Ford, D
Dearnaley, D
Ardern-Jones, A
Murkin, A
Dowe, A
Shearer, R
Kelly, J
Labrie, F
Easton, D
Narod, SA
Tonin, PN
Foulkes, WD
Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247
Authors:
Dion, F
Mes-Masson, AM
Seymour, RJ
Provencher, D
Tonin, PN
Citation: F. Dion et al., Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers, ONCOGENE, 19(11), 2000, pp. 1466-1472
Authors:
Manderson, EN
Mes-Masson, AM
Provencher, D
Tonin, PN
Citation: En. Manderson et al., Mutations in a 10-bp polyadenine repeat of transforming growth factor beta-receptor type II gene is an infrequent event in human epithelial ovarian cancer, CLIN GENET, 57(2), 2000, pp. 151-153
Authors:
Manning, AP
Mes-Masson, AM
Seymour, RJ
Tetrault, M
Provencher, DM
Tonin, PN
Citation: Ap. Manning et al., Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites, MOL CARCINO, 24(3), 1999, pp. 218-225
Authors:
Hamel, N
Manning, A
Black, MJ
Tonin, PN
Foulkes, WD
Citation: N. Hamel et al., An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck, INT J CANC, 83(6), 1999, pp. 803-804
Authors:
Tonin, PN
Mes-Masson, AM
Narod, SA
Ghadirian, P
Provencher, D
Citation: Pn. Tonin et al., Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history, CLIN GENET, 55(5), 1999, pp. 318-324